Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit.

E A Chrysochoou, E Hatziagorou, F Kirvassilis, J Tsanakas

Open access · greenAbstract read

In one paragraph

Article in Hippokratia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.5field-weighted citation impact, top 26% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

Outpatient Parenteral Antimicrobial Therapy in Children.Current infectious disease reports · 2019
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

E A Chrysochoou3 Pediatric Department, Pediatric Pulmonology and Cystic Fibrosis Unit, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

E Hatziagorou3 Pediatric Department, Pediatric Pulmonology and Cystic Fibrosis Unit, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

F Kirvassilis3 Pediatric Department, Pediatric Pulmonology and Cystic Fibrosis Unit, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

J Tsanakas3 Pediatric Department, Pediatric Pulmonology and Cystic Fibrosis Unit, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece.

Aristotle University of Thessaloniki · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric home care has improved therapeutic options for children with chronic disease. Home intravenous (IV) antibiotic treatment against

methodThe clinical outcome, quality of life, and cost benefits of home versus hospital antibiotic treatment were assessed. The clinical outcome was evaluated with Forced Expiratory Volume in one second (FEV

resultsThirty-five stable patients with CF (mean age: 12.6 ± 7 years, 56 % male, mean FEV

conclusionsHome IV antibiotic therapy monitored by a home care nurse, is a safe, efficient, and cost-saving therapeutic option in CF. Hippokratia 2016, 20(4): 279-283.

Indexed as

antibiotic therapyCystic FibrosishomecareintravenousPseudomonas aeruginosaquality of life

Identifiers

PMID29416300

PMCPMC5788226

OpenAlexW2944565654

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.